Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome: An unusual presentation of anti-GFAP astrocytopathy

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare recently defined antibody-mediated encephalitis. Meningo-encephalomyelitis presentation is frequent with lymphocytic pleiocytosis in the cerebro-spinal fluid and brain MRI classically demonstrates in 50% of cases, a linear pe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of paediatric neurology 2020-05, Vol.26, p.89-91
Hauptverfasser: Oger, Valentin, Bost, Chloé, Salah, Lucie, Yazbeck, Elise, Maurey, Hélène, Bellesme, Céline, Sevin, Caroline, Adamsbaum, Catherine, Chrétien, Pascale, Benaiteau, Marie, Honnorat, Jérôme, Deiva, Kumaran
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare recently defined antibody-mediated encephalitis. Meningo-encephalomyelitis presentation is frequent with lymphocytic pleiocytosis in the cerebro-spinal fluid and brain MRI classically demonstrates in 50% of cases, a linear perivascular enhancement extending radially from the ventricles. Here, we describe 2 cases of pediatric autoimmune GFAP astrocytopathy with limbic encephalitis presentation and peculiar MRI characteristics: one with normal MRI and the second suggestive of Mild Encephalitis/Encephalopathy with reversible splenial lesion syndrome (MERS). These two cases illustrate that anti-GFAP antibodies should be sought in children presenting limbic encephalitis with a normal and/or MERS suggestive MRI, as treatment strategies may differ. •Anti-GFAP astrocytopathy is a rare condition in adults and children and specific MRI lesions have been suggested.•Clinical outcome is good in most of the cases after immunotherapies.•The pathogenicity of anti-GFAP antibodies is far from being demonstrated.•Anti-GFAP antibodies should be tested for meningo-encephalitis with normal or MERS suggestive MRI, as treatment may differ.
ISSN:1090-3798
1532-2130
DOI:10.1016/j.ejpn.2020.03.002